Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis
- 1 April 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 92 (4) , S108-S113
- https://doi.org/10.1016/0002-9343(92)90320-b
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Fluoroquinolone Antimicrobial AgentsNew England Journal of Medicine, 1991
- Concentrations of oral lomefloxacin in serum and bronchial mucosaAntimicrobial Agents and Chemotherapy, 1990
- Fluoroquinolone antimicrobial agentsClinical Microbiology Reviews, 1989
- Epidemiology of Chronic Airways DiseaseChest, 1989
- Effect of lomefloxacin on theophylline pharmacokineticsAntimicrobial Agents and Chemotherapy, 1989
- Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral dosesAntimicrobial Agents and Chemotherapy, 1988
- Quinolones: A New Class of Antimicrobial Agents with Wide Potential UsesMedical Clinics of North America, 1988
- In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesAntimicrobial Agents and Chemotherapy, 1988
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987
- Role of Infection in Chronic BronchitisNew England Journal of Medicine, 1975